Efficacy of Add-on Montelukast in Nonasthmatic Eosinophilic Bronchitis: The Additive Effect on Airway Inflammation, Cough and Life Quality

Efficacy of Add-on Montelukast in Nonasthmatic Eosinophilic Bronchitis: The Additive Effect on Airway Inflammation, Cough and Life Quality

Background: The efficacy of montelukast (MONT), a cysteinyl leukotriene receptor antagonist, in nonasthmatic eosinophilic bronchitis (NAEB), especially its influence on cough associated life quality is still indefinite. We evaluated the efficacy of MONT combined with budesonide (BUD) as compared to...

Description complète

Détails bibliographiques
Auteurs principaux: Wuping Bao, Ping Liu, Zhongmin Qiu, Li Yu, Jingqing Hang, Xiaohua Gao, Xin Zhou
Format: Article
Langue:English
Publié: Wolters Kluwer 2015-01-01
Collection:Chinese Medical Journal
Sujets:
Budesonide; Cough; Quality of Life; Montelukast; Bronchitis
Accès en ligne:http://www.cmj.org/article.asp?issn=0366-6999;year=2015;volume=128;issue=1;spage=39;epage=45;aulast=Bao

Internet

http://www.cmj.org/article.asp?issn=0366-6999;year=2015;volume=128;issue=1;spage=39;epage=45;aulast=Bao

Documents similaires